SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-319568"
 

Search: onr:"swepub:oai:DiVA.org:uu-319568" > Pneumococcal polysa...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Pneumococcal polysaccharide vaccination administered early after neurotrauma or neurosurgery

Ljunghill Hedberg, Anna (author)
Uppsala universitet,Infektionssjukdomar
Pauksens, Karlis (author)
Uppsala universitet,Infektionssjukdomar
Enblad, Per (author)
Uppsala universitet,Neurokirurgi
show more...
Söderberg, Jessika (author)
Uppsala universitet,Infektionssjukdomar
Johansson, Björn (author)
Uppsala universitet,Rehabiliteringsmedicin
Kayhty, Helena (author)
Natl Inst Hlth & Welf, Helsinki, Finland.
Sjölin, Jan (author)
Uppsala universitet,Infektionssjukdomar
show less...
 (creator_code:org_t)
ELSEVIER SCI LTD, 2017
2017
English.
In: Vaccine. - : ELSEVIER SCI LTD. - 0264-410X .- 1873-2518. ; 35:6, s. 909-915
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Objectives: Pneumococcal vaccination is recommended to lower the risk of posttraumatic meningitis, and early vaccination may be of importance. After both trauma and central nervous system injury, immune suppression may occur, which could affect T-cell function and the response to T-cell dependent vaccines. We therefore aimed to investigate the response to early vaccination with a T-cell independent pneumococcal polysaccharide vaccine (PPSV). Methods: Thirty-three patients with basilar skull fracture and 23 patients undergoing transsphenoidal pituitary gland surgery were vaccinated with PPSV within 10 days after neurotrauma or neurosurgery. Twenty-nine neurosurgical patients vaccinated >= 3 weeks after neurotrauma or neurosurgery served as controls. Serotype-specific anti-polysaccharide binding IgG antibody levels to serotypes 4, 6B, 9V, 14, 18C, 19F and 23F were determined by enzyme immunoassay. Results: The vaccination was safe and a highly significant antibody response was found against all serotypes in all groups (p < 0.001 for each of the serotypes). There were no differences between groups or in the group by time interaction in any of the serotypes. After early and late vaccination, protective levels were found in >80% for serotypes 9V, 14, 18C, 19F and 23F and in 70% and 50% for serotypes 6B and 4, respectively. Conclusion: Patients vaccinated with PPSV within 10 days after neurotrauma or neurosurgery respond similarly to those vaccinated after >= 3 weeks, indicating that PPSV can be administered early after neurotrauma or neurosurgery.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Infektionsmedicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Infectious Medicine (hsv//eng)
MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Immunologi inom det medicinska området (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Immunology in the medical area (hsv//eng)

Keyword

Pneumococcal polysaccharide vaccine
Neurotrauma
Neurosurgery

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

  • Vaccine (Search for host publication in LIBRIS)

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view